Concepts (90)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thalamic Nuclei | 1 | 2024 | 24 | 0.860 |
Why?
|
| Schizophrenia | 1 | 2024 | 263 | 0.740 |
Why?
|
| Cognitive Dysfunction | 1 | 2024 | 332 | 0.650 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 722 | 0.540 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2015 | 491 | 0.250 |
Why?
|
| Organ Size | 1 | 2024 | 170 | 0.220 |
Why?
|
| Functional Laterality | 1 | 2024 | 138 | 0.210 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2013 | 719 | 0.200 |
Why?
|
| Gene Expression Profiling | 3 | 2021 | 770 | 0.180 |
Why?
|
| Lupus Erythematosus, Discoid | 1 | 2021 | 8 | 0.180 |
Why?
|
| Lupus Erythematosus, Cutaneous | 1 | 2021 | 13 | 0.180 |
Why?
|
| Lupus Nephritis | 1 | 2021 | 37 | 0.170 |
Why?
|
| Skin | 1 | 2021 | 373 | 0.140 |
Why?
|
| Tissue Banks | 1 | 2015 | 5 | 0.120 |
Why?
|
| Tissue and Organ Procurement | 1 | 2015 | 43 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2024 | 2188 | 0.110 |
Why?
|
| Genetic Variation | 2 | 2013 | 384 | 0.110 |
Why?
|
| Lipocalins | 1 | 2013 | 4 | 0.100 |
Why?
|
| Apolipoproteins | 1 | 2013 | 14 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2013 | 4 | 0.100 |
Why?
|
| Aged | 5 | 2024 | 14524 | 0.100 |
Why?
|
| Cholesterol, HDL | 1 | 2013 | 73 | 0.100 |
Why?
|
| Emphysema | 1 | 2013 | 39 | 0.100 |
Why?
|
| Genome-Wide Association Study | 2 | 2013 | 359 | 0.100 |
Why?
|
| Genome, Human | 1 | 2015 | 237 | 0.100 |
Why?
|
| Biomedical Research | 1 | 2015 | 270 | 0.100 |
Why?
|
| Middle Aged | 5 | 2024 | 17711 | 0.090 |
Why?
|
| Cotinine | 1 | 2011 | 19 | 0.090 |
Why?
|
| Male | 8 | 2024 | 30008 | 0.090 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2011 | 15 | 0.090 |
Why?
|
| Transcriptome | 1 | 2015 | 386 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2011 | 6 | 0.090 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 1618 | 0.090 |
Why?
|
| Alcohol Drinking | 1 | 2013 | 314 | 0.080 |
Why?
|
| Female | 7 | 2024 | 33026 | 0.080 |
Why?
|
| Alcoholism | 1 | 2013 | 317 | 0.080 |
Why?
|
| Atherosclerosis | 1 | 2011 | 154 | 0.080 |
Why?
|
| Body Mass Index | 1 | 2013 | 869 | 0.080 |
Why?
|
| Tobacco Use Disorder | 1 | 2011 | 246 | 0.080 |
Why?
|
| Humans | 11 | 2024 | 63643 | 0.070 |
Why?
|
| Genetic Loci | 3 | 2013 | 116 | 0.070 |
Why?
|
| Asthma | 1 | 2013 | 466 | 0.070 |
Why?
|
| Lung | 1 | 2013 | 955 | 0.070 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 697 | 0.060 |
Why?
|
| Genotype | 3 | 2013 | 662 | 0.060 |
Why?
|
| Smoking | 1 | 2011 | 866 | 0.060 |
Why?
|
| Cohort Studies | 4 | 2013 | 2576 | 0.060 |
Why?
|
| Phenotype | 3 | 2015 | 1207 | 0.060 |
Why?
|
| Obesity | 1 | 2013 | 1235 | 0.060 |
Why?
|
| Atrial Fibrillation | 1 | 2011 | 838 | 0.050 |
Why?
|
| Genetic Association Studies | 2 | 2013 | 120 | 0.050 |
Why?
|
| Gene Ontology | 1 | 2021 | 38 | 0.040 |
Why?
|
| Chemokines | 1 | 2021 | 93 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2013 | 1121 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2015 | 195 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2015 | 127 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 174 | 0.030 |
Why?
|
| Apolipoproteins M | 1 | 2013 | 1 | 0.030 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 2013 | 5 | 0.030 |
Why?
|
| Receptors, Interleukin-18 | 1 | 2013 | 10 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2013 | 47 | 0.030 |
Why?
|
| Interleukin-13 | 1 | 2013 | 37 | 0.030 |
Why?
|
| Vital Capacity | 1 | 2013 | 118 | 0.030 |
Why?
|
| Spirometry | 1 | 2013 | 112 | 0.030 |
Why?
|
| DNA Repair Enzymes | 1 | 2013 | 37 | 0.030 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2013 | 66 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2013 | 123 | 0.020 |
Why?
|
| Forced Expiratory Volume | 1 | 2013 | 209 | 0.020 |
Why?
|
| Risk | 1 | 2013 | 378 | 0.020 |
Why?
|
| Sex Factors | 1 | 2015 | 979 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2011 | 17 | 0.020 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2011 | 19 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2013 | 281 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2011 | 35 | 0.020 |
Why?
|
| Risk Factors | 2 | 2011 | 5367 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2013 | 571 | 0.020 |
Why?
|
| Receptors, Nicotinic | 1 | 2011 | 67 | 0.020 |
Why?
|
| Alleles | 1 | 2011 | 447 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 517 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2011 | 518 | 0.020 |
Why?
|
| United States | 2 | 2013 | 7868 | 0.020 |
Why?
|
| Incidence | 1 | 2013 | 1385 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 424 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2013 | 899 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 1185 | 0.020 |
Why?
|
| Prognosis | 1 | 2011 | 1748 | 0.020 |
Why?
|
| Adult | 2 | 2013 | 16902 | 0.010 |
Why?
|
| Stroke | 1 | 2011 | 1197 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 4717 | 0.010 |
Why?
|
| Adolescent | 1 | 2011 | 6260 | 0.010 |
Why?
|